Home Tirzepatide Tools
Tirzepatide Tools
Four calculators built on the same tracked pricing dataset as our tables. No signup.
Every tool here runs in your browser against the same pricing dataset that generates our tables, which carries a verification date on every record. Nothing is submitted anywhere and no account is required.
They exist because the single most useful thing you can do before enrolling is price the dose you will actually maintain on rather than the dose in the advertisement.
Calculators
Twelve-month cost projector
Model a full year at your maintenance dose across every tracked program.
Savings calculator
Compare what you pay now against the cheapest tracked price, annualised.
Dose planner
Turn the four-week titration rule into real calendar dates.
Brand vs compounded
What FDA approval status costs you over a year, as a number.
Full price calculator
The complete six-dose, sixteen-program comparison.
Price by dose table
Every strength, every programme, twelve-month totals.
Eligibility checker
The labelled BMI thresholds applied to your numbers.
Prepaid break-even
What a multi-month discount saves, and what it puts at risk.
Cold-chain planner
Whether your shipment will survive the last hundred feet.
Switching cost
The annual saving, net of a supply gap and re-titration.
Dose-step cost timeline
What each rung of the ladder costs at one programme.
Multi-year cost
What treating a chronic condition totals over years.
Legitimacy checker
Six checks on any programme's own site, scored — two are disqualifying on their own.
Coverage checker
What your plan type and indication mean, including the Medicare GLP-1 Bridge.
Titration cost planner
Set your own escalation pace and re-rank the whole market against it.
Program matcher
Four questions, ranked against every tracked program.
Full price calculator
Six doses, every program, one screen.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.